Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)

키워드

참고문헌 (85)

1. Potter MB, "Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally", Annu Rev Public Health, 34, pp.413~429 (2013)
2. Jemal A, "Global patterns of cancer incidence and mortality rates and trends", Cancer Epidemiol Biomarkers Prev, 19, pp.1893~1907 (2010)
3. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
4. Center MM, "Worldwide variations in colorectal cancer", CA Cancer J Clin, 59, pp.366~378 (2009)
5. Hardcastle JD, "Randomised controlled trial of faecal-occult-blood screening for colorectal cancer", Lancet, 348 (1996)
6. Kronborg O, "Randomised study of screening for colorectal cancer with faecaloccult-blood test", Lancet, 348, pp.1467~1471 (1996)
7. Mandel JS, "The effect of fecal occultblood screening on the incidence of colorectal cancer", N Engl J Med, 343, pp.1603~1607 (2000)
8. Hoff G, "Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening:randomised controlled trial", BMJ, 338, pp.b1846~ (2009)
9. Atkin WS, "Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial", Lancet, 375, pp.1624~1633 (2010)
10. Segnan N, "Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial: SCORE", J Natl Cancer Inst, 103, pp.1310~1322 (2011)
11. Schoen RE, "Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy", N Engl J Med, 366, pp.2345~2357 (2012)
12. Shaukat A, "Long-term mortality after screening for colorectal cancer", N Engl J Med, 369, pp.1106~1114 (2013)
13. Segnan N, "European guidelines for quality assurance in colorectal cancer screening and diagnosis" (2010), Publications Office of the European Union
14. Halloran SP, "International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis: first Edition: faecal occult blood testing", Endoscopy, 44(Suppl 3), pp.SE65~SE87 (2012)
15. Imperiale TF, "Noninvasive screening tests for colorectal cancer", Dig Dis, 30(Suppl 2), pp.16~26 (2012)
16. Levin B, "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology", Gastroenterology, 134, pp.1570~1595 (2008)
17. Ahlquist DA, "Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel", Gastroenterology, 119, pp.1219~1227 (2000)
18. Osborn NK, "Stool screening for colorectal cancer:molecular approaches", Gastroenterology, 128, pp.192~206 (2005)
19. Cole SR, "Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer", Med J Aust, 175, pp.195~198 (2001)
20. Cole SR, "A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer", J Med Screen, 10, pp.117~122 (2003)
21. Vart G, "Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis", Prev Med, 55, pp.87~92 (2012)
22. Digby J, "Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme", J Med Screen, 20, pp.80~85 (2013)
23. Fleisher M, "Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group", Ann Intern Med, 114, pp.875~876 (1991)
24. Niv Y, "Fecal occult blood test: the importance of proper evaluation", J Clin Gastroenterol, 12, pp.393~395 (1990)
25. Burtonwood C, "Monitoring faecal occult blood test positivity in the NHS bowel cancer screening programme", Gut, 61, pp.A334~ (2012)
26. Steele RJ, "Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity", United Eur Gastroenterol J, 1, pp.198~205 (2013)
27. Stegeman I, "Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy", Gut, 63, pp.466~471 (2014)
28. Simon JB, "Occult blood screening for colorectal carcinoma: a critical review", Gastroenterology, 88, pp.820~837 (1985)
29. Barrows GH, "Immunochemical detection of human blood in feces", Am J Clin Pathol, 69, pp.342~346 (1978)
30. Songster CL, "Colorectal cancer, prevention, epidemiology, and screening. Volume 13", pp.193~204 (1980), Raven Press
31. Songster CL, "Immunochemical detection of fecal occult blood: the fecal smear punch-disc test: a new noninvasive screening test for colorectal cancer", Cancer, 45(5Suppl), pp.1099~1102 (1980)
32. Vellacott KD, "An immunofluorescent test for faecal occult blood", Lancet, 1, pp.18~19 (1981)
33. St John DJ, "Evaluation of new occult blood tests for detection of colorectal neoplasia", Gastroenterology, 104, pp.1661~1668 (1993)
34. Williams JA, "Evaluation of an immunological test for occult bleeding from colorectal neoplasia", Aust N Z J Surg, 52, pp.617~621 (1982)
35. Robinson MH, "Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests", Br J Surg, 81, pp.448~451 (1994)
36. Rozen P, "Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia", Eur J Cancer Prev, 4, pp.475~481 (1995)
37. Allison JE, "A comparison of fecal occult-blood tests for colorectal-cancer screening", N Engl J Med, 334, pp.155~159 (1996)
38. Petrelli N, "Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program", Surg Oncol, 3, pp.27~36 (1994)
39. Allison JE, "Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics", J Natl Cancer Inst, 99, pp.1462~1470 (2007)
40. Levi Z, "A quantitative immunochemical fecal occult blood test for colorectal neoplasia", Ann Intern Med, 146, pp.244~255 (2007)
41. Morikawa T, "A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population", Gastroenterology, 129, pp.422~428 (2005)
42. Park DI, "Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening", Am J Gastroenterol, 105, pp.2017~2025 (2010)
43. van Rossum LG, "Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population", Gastroenterology, 135, pp.82~90 (2008)
44. Allison JE, "The imperative of equal funding for studies that evaluate any of the evidence-based, guideline-recommended colorectal cancer screening tests", Clin Gastroenterol Hepatol, 7, pp.1269~1271 (2009)
45. Saito H, "Screening for colorectal cancer by immunochemical fecal occult blood testing", Jpn J Cancer Res, 87, pp.1011~1124 (1996)
46. Saito H, "Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study", Int J Cancer, 61, pp.465~469 (1995)
47. Shimbo T, "Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan", Int J Technol Assess Health Care, 10, pp.359~375 (1994)
48. Cole P, "Basic issues in population screening for cancer", J Natl Cancer Inst, 64, pp.1263~1272 (1980)
49. Levi Z, "A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test", Aliment Pharmacol Ther, 23, pp.1359~1364 (2006)
50. Young GP, "Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy?", Gut, 61, pp.959~960 (2012)
51. Fletcher RH, "Commentary", ACP J Club, 124, pp.74~ (1996)
52. Cole SR, "Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program", Med J Aust, 198, pp.327~330 (2013)
53. Ventura L, "The impact of immunochemical faecal occult blood testing on colorectal cancer incidence", Dig Liver Dis, 46, pp.82~86 (2014)
54. Zauber AG, "Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force", Ann Intern Med, 149, pp.659~669 (2008)
55. "Tools & resources:the new FOBT clinician’s reference resource" (2002)[URL]
56. Qaseem A, "Screening for colorectal cancer: a guidance statement from the American College of Physicians", Ann Intern Med, 156, pp.378~386 (2012)
57. Sugerman DT, "JAMA Patient Page: options for colorectal cancer screening", JAMA, 310, pp.658~ (2013)
58. Quintero E, "Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening", N Engl J Med, 366, pp.697~706 (2012)
59. Allison JE, "Comparing fecal immunochemical tests: improved standardization is needed", Gastroenterology, 142, pp.422~424 (2012)
60. Fraser CG, "Newer fecal tests:opportunities for professionals in laboratory medicine", Clin Chem, 58, pp.963~965 (2012)
61. Fraser CG, "Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin(FIT)", Clin Chem Lab Med, pp.1~3 (2013)
62. Fraser CG, "Expert Working Group on Fecal Immunochemical Tests for Hemoglobin, Colorectal Cancer Screening Committee, World Endoscopy Organization. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin", J Natl Cancer Inst, 104, pp.810~814 (2012)
63. Fraser CG, "Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening", Clin Gastroenterol Hepatol, 11, pp.839~840 (2013)
64. Tao S, "Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer", Acta Oncol, 52(1), pp.1667~1675 (2013)
65. Grazzini G, "Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district", Gut, 59, pp.1511~1515 (2010)
66. van Roon AH, "Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial", Am J Gastroenterol, 107, pp.99~107 (2012)
67. "Evaluation of quantitative faecal immunochemical tests for haemoglobin" (2013)[URL]
68. Hol L, "Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy", Gut, 59, pp.62~68 (2010)
69. Steele RJ, "Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer", Gut, 58, pp.530~535 (2009)
70. Denters MJ, "Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer", Gastroenterology, 142, pp.497~504 (2012)
71. van Roon AH, "Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening", Gut, 62, pp.409~415 (2013)
72. Crotta S, "High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test", Clin Gastroenterol Hepatol, 10, pp.633~638 (2012)
73. Potter MB, "Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial", Am J Public Health, 103, pp.1128~1133 (2013)
74. Potter MB, "Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign", J Am Pharm Assoc (2003), 50, pp.181~187 (2010)
75. Potter MB, "Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates", Ann Fam Med, 7, pp.17~23 (2009)
76. Potter MB, "The FLU-FIT program:an effective colorectal cancer screening program for high volume flu shot clinics", Am J Manag Care, 17, pp.577~583 (2011)
77. Walsh JM, "The FLU-FOBT Program in community clinics: durable benefits of a randomized controlled trial", Health Educ Res, 27, pp.886~894 (2012)
78. Zajac IT, "Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis", J Med Screen, 17, pp.19~24 (2010)
79. Hewitson P, "Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial", Br J Cancer, 105, pp.475~480 (2011)
80. van Roon AH, "Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance", Clin Gastroenterol Hepatol, 9, pp.333~339 (2011)
81. Raginel T, "A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening", Gastroenterology, 144, pp.918~925 (2013)
82. Imperiale TF, "Quantitative immunochemical fecal occult blood tests: is it time to go back to the future?", Ann Intern Med, 146, pp.309~311 (2007)
83. Fraser CG, "A future for faecal haemoglobin measurements in the medical laboratory", Ann Clin Biochem, 49(Pt 6), pp.518~526 (2012)
84. Brenner H, "Sex differences in performance of fecal occult blood testing", Am J Gastroenterol, 105, pp.2457~2464 (2010)
85. Khalid-de Bakker CA, "Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas", Cancer Prev Res (Phila), 4, pp.1563~1571 (2011)

관련 논문AI추천